All Press Releases
Pila Pharma AB announces outcome in the rights issue
Malmö, 5 December 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION…
THE ONGOING RIGHTS ISSUE IN PILA PHARMA HAS ENTERED ITS LAST SUBSCRIPTION WEEK AND WILL END MONDAY 4 DECEMBER. THE LAST DAY OF TRADING SUBSCRIPTION RIGHTS IS WEDNESDAY 29 NOVEMBER
Malmö, 29 November 2023 Pila Pharma AB (publ) ("Pila Pharma" or the "Company") hereby informs that the subscription period in Company's rights issue of shares that was initiated on 20 November 2023 has entered its second subscription week and and will run until Monday 4 December 2023. The last day of trading subscription rights is today, Wednesday 29 November 2023…
PILA PHARMA WILL PRESENT AT “STORA AKTIEDAGARNA” IN STOCKHOLM TOMORROW, 27 NOVEMBER 2023 AT 8:00 CET
Malmö, 26 November 2023 On Monday 27 November 2023 at 8:00 CET, the CEO of Pila Pharma will present the company's business and ongoing rights issue at the event "Stora Aktiedagarna" in Stockholm. The presentation can be viewed onsite or via live stream. Adress: Birger Jarlsgatan 61 A, Stockholm Live stream: https://invitepeople.com/public/events/af87c9f59a/pages/aa3d4312cf No registration is needed for the digital live stream…